Cleared Traditional

K220731 - Insignia Hip Stem

K220731 is the FDA 510(k) clearance for Insignia Hip Stem by Stryker. It is a Class 2 Orthopedic device (product code MEH) cleared through the Traditional 510(k) pathway after a 150-day FDA review.

K220731 · Stryker · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2022
Decision
150d
Days
Class 2
Risk

K220731 is an FDA 510(k) clearance for the Insignia Hip Stem, Restoration Modular 115mm Conical Distal Stem. Classified as Prosthesis, Hip, Semi-constrained, Uncemented, Metal / Polymer, Non-porous, Calcium Phosphate (product code MEH), Class II - Special Controls.

Submitted by Stryker (Mahwah, US). The FDA issued a Cleared decision on August 11, 2022 after a review of 150 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3353 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Stryker devices

Submission Details

510(k) Number K220731 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 14, 2022
Decision Date August 11, 2022
Days to Decision 150 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
28d slower than avg
Panel avg: 122d · This submission: 150d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MEH Prosthesis, Hip, Semi-constrained, Uncemented, Metal / Polymer, Non-porous, Calcium Phosphate
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3353
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MEH Prosthesis, Hip, Semi-constrained, Uncemented, Metal / Polymer, Non-porous, Calcium Phosphate

All 126
Devices cleared under the same product code (MEH) and FDA review panel - the closest regulatory comparables to K220731.
DePuy SUMMIT Porocoat Hip Prosthesis – MR Conditional, DePuy SUMMIT DuoFix Hip Prosthesis – MR Conditional, DePuy SUMMIT Cemented Hip Prosthesis – MR Conditional, DePuy SUMMIT FX Cemented Hip Prosthesis – MR Conditional, DePuy SUMMIT Basic Press-Fit Hip Prosthesis – MR Conditional
K231873 · Depuy Ireland UC · Jan 2024
ACTERA™ hip system
K231178 · Conformis, Inc. · May 2023
SignaSure Dual Mobility System
K220495 · Signature Orthopaedics Pty, Ltd. · Jan 2023
Actera™ hip system
K221104 · Conformis, Inc. · Aug 2022
SignaSure Dual Mobility System
K211742 · Signature Orthopaedics Pty, Ltd. · Jan 2022
Encore Hip Stem
K211505 · Signature Orthopaedics Pty, Ltd. · Sep 2021